Compare the incidence of cardiopulmonary adverse events and airway interventions between OSA screening scale high-risk and low-risk patients undergoing bronchoscopy with deep sedation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300075315

Enrollment

Unknown

Registered

2023-09-01

Start date

2023-09-01

Completion date

Unknown

Last updated

2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea

Interventions

OSA high-risk group:None

OSA low-risk group:None

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Patients planning to undergo deep sedation bronchoscopy examination 2.Age>18 years old 3. ASA Classification I - III

Exclusion criteria

Exclusion criteria: 1. coagulopathy disorders defined by coagulopathy function or a tendency for nose bleeding 2.severe cardiac disease, including aortic ste- nosis, mitral stenosis, haemodynamic instability caused by severe arrhythmia, and acute myocardial infarction or cardiac surgery within the last 6 months 3.severe oxygen desaturation (SpO2 < 90% without oxygen supply on admission) 4.upper respiratory tract infection or lung infection. 5.refusal to participate in this study. 6.patients undergoing bronchoalveolar lavage (BAL), radial and convex probe endo bronchial ultrasound (EBUS), navigational bronchoscopy, and interventional bronchoscopy

Design outcomes

Primary

Measure	Time frame
Blood oxygen saturation;airway maneuvers;	—

Secondary

Measure	Time frame
blood pressure;heart rate;tachycardia;bradycardia;Airway collapse;	—

Countries

China

Contacts

Public ContactZhu Ding

Zhejiang Cancer Hospital

zhudingqd@163.com+86 187 6810 2401

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026